| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | $199,280,597 | 4,278,244 | FMR LLC | 31 Oct 2025 | |||
| RA CAPITAL MANAGEMENT, L.P. | 14% | -10% | $198,668,637 | +$209,610 | 4,265,106 | +0.11% | RA Capital Management, L.P. | 05 Nov 2025 |
| BlackRock, Inc. | 4.9% | -4% | $24,603,568 | +$1,517,744 | 1,537,723 | +6.6% | BlackRock, Inc. | 31 Dec 2025 |
| Point72 Asset Management, L.P. | 4.8% | $63,244,042 | 1,357,751 | Steven A. Cohen | 30 Sep 2025 | |||
| Paradigm Biocapital Advisors LP | 3.8% | -28% | $50,001,813 | -$16,133,961 | 1,073,461 | -24% | Paradigm BioCapital Advisors LP | 30 Sep 2025 |
| Versant Venture Capital VI, L.P. | 3.4% | -18% | $48,936,901 | -$6,192,532 | 1,050,599 | -11% | Versant Venture Capital VI, L.P. | 05 Nov 2025 |
As of 30 Sep 2025, 166 institutional investors reported holding 29,140,610 shares of LENZ Therapeutics, Inc. - Common Stock (LENZ). This represents 93% of the company’s total 31,382,102 outstanding shares.
The largest institutional shareholders of LENZ Therapeutics, Inc. - Common Stock (LENZ) together control 78% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 13% | 4,178,823 | 0% | 2.4% | $194,649,575 |
| Alpha Wave Global, LP | 12% | 3,612,211 | 0% | 17% | $168,256,788 |
| Versant Venture Management, LLC | 8.5% | 2,656,888 | 58% | $123,757,843 | |
| BlackRock, Inc. | 4.7% | 1,473,104 | +2.8% | 0% | $68,617,185 |
| VANGUARD GROUP INC | 4.2% | 1,330,286 | +3% | 0% | $61,964,723 |
| UBS Group AG | 3.8% | 1,201,616 | +36% | 0.01% | $55,971,274 |
| Paradigm Biocapital Advisors LP | 3.4% | 1,073,461 | -37% | 1.5% | $50,001,813 |
| 72 Investment Holdings, LLC | 3.2% | 1,017,751 | 0% | 70% | $47,406,842 |
| TANG CAPITAL MANAGEMENT LLC | 2.9% | 897,616 | 0% | 1.6% | $41,810,953 |
| RTW INVESTMENTS, LP | 2.8% | 863,389 | 0% | 0.5% | $40,216,660 |
| First Light Asset Management, LLC | 2.2% | 693,044 | 3% | $32,281,990 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2% | 627,618 | -44% | 0.05% | $29,234,446 |
| FRANKLIN RESOURCES INC | 1.9% | 587,084 | +6756% | 0.01% | $27,346,372 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.4% | 454,896 | +9.3% | 0% | $21,193,422 |
| STATE STREET CORP | 1.3% | 417,984 | +11% | 0% | $19,469,695 |
| CITADEL ADVISORS LLC | 1.3% | 399,430 | +4320% | 0.01% | $18,605,449 |
| Saturn V Capital Management LP | 1.2% | 368,176 | +7.6% | 3.8% | $17,149,638 |
| Invesco Ltd. | 1.2% | 364,265 | +37% | 0% | $16,967,463 |
| BANK OF AMERICA CORP /DE/ | 1.1% | 349,128 | +414% | 0% | $16,262,383 |
| SAMSARA BIOCAPITAL, LLC | 1.1% | 343,012 | 0% | 2.1% | $15,977,499 |
| Point72 Asset Management, L.P. | 1.1% | 340,000 | -45% | 0.03% | $15,837,200 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1% | 323,857 | +35% | 0.49% | $15,085,259 |
| MORGAN STANLEY | 0.94% | 296,219 | -49% | 0% | $13,797,880 |
| Nuveen, LLC | 0.91% | 285,543 | +60% | 0% | $13,300,593 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 0.8% | 251,131 | +1582% | 0% | $11,699,000 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 775,366 | $12,819,564 | +$6,467,470 | $16.00 | 11 |
| 2025 Q3 | 29,140,610 | $1,355,578,952 | +$224,910,234 | $46.58 | 166 |
| 2025 Q2 | 24,727,156 | $725,109,733 | +$107,969,187 | $29.31 | 113 |
| 2025 Q1 | 21,072,237 | $541,761,121 | +$29,092,976 | $25.71 | 105 |
| 2024 Q4 | 19,863,850 | $573,239,116 | +$35,341,897 | $28.87 | 94 |
| 2024 Q3 | 18,735,645 | $444,795,067 | -$1,423,016 | $23.74 | 78 |
| 2024 Q2 | 18,913,542 | $327,016,869 | +$45,118,057 | $17.29 | 63 |
| 2024 Q1 | 16,171,755 | $361,085,230 | +$360,723,016 | $22.33 | 54 |